Korekiyo Wakitani
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Peroxisome Proliferator-Activated Receptors, Synthesis and biological activity, Metabolism, Diabetes, and Cancer, Eicosanoids and Hypertension Pharmacology
Most-Cited Works
- → A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits(2000)526 cited
- → 4-(4-Cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as Selective Cyclooxygenase-2 Inhibitors: Enhancement of the Selectivity by Introduction of a Fluorine Atom and Identification of a Potent, Highly Selective, and Orally Active COX-2 Inhibitor JTE-522(2002)121 cited
- → Effects of peroxisome proliferator‐activated receptor‐α and ‐γ agonist, JTT‐501, on diabetic complications in Zucker diabetic fatty rats(2000)90 cited
- → Isoxazolidine-3,5-dione and Noncyclic 1,3-Dicarbonyl Compounds as Hypoglycemic Agents(1998)77 cited
- → Pharmacological Studies on the TXA2 Synthetase Inhibitor (E)-3-[p(1H-lmidazol-1-Ylmethyl)Phenyl]-2-Propenoic Acid (OKY-046)(1986)63 cited
- → Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative(1999)52 cited
- → Profile of JTE-522 as a Human Cyclooxygenase-2 Inhibitor(1998)49 cited
- → Intestinal fatty acid infusion modulates food preference as well as calorie intake via the vagal nerve and midbrain–hypothalamic neural pathways in rats(2012)28 cited
- → Synthesis and Structure−Activity Relationships of 5,6,7,8-Tetrahydro-4H-thieno[3,2-b]azepine Derivatives: Novel Arginine Vasopressin Antagonists(2003)27 cited
- → Effect of JTT-705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals(2003)27 cited